16 January 2025
Cancers | Highly Viewed Papers in 2024 and Hot Topic Special Issues on Cancer Metastasis

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
We are delighted to share some highly viewed papers on cancer metastasis that were published in Cancers (ISSN: 2072-6694) in 2024. In addition, some Special Issues on this topic are open for submission. The following is a list of articles and Special Issues that we believe will interest you.
“A Systematic Review on Artificial Intelligence Evaluating Metastatic Prostatic Cancer and Lymph Nodes on PSMA PET Scans”
by Jianliang Liu, Thomas P. Cundy, Dixon T. S. Woon and Nathan Lawrentschuk
Cancers 2024, 16(3), 486; https://doi.org/10.3390/cancers16030486
Available online: https://www.mdpi.com/2072-6694/16/3/486
“Novel Therapeutic Targets on the Horizon: An Analysis of Clinical Trials on Therapies for Bone Metastasis in Prostate Cancer”
by Wenhao Zhou, Wei Zhang, Shi Yan, Kaixuan Zhang, Han Wu, Hongyu Chen, Minfeng Shi and Tie Zhou
Cancers 2024, 16(3), 627; https://doi.org/10.3390/cancers16030627
Available online: https://www.mdpi.com/2072-6694/16/3/627
“Role of Hypoxia and Rac1 Inhibition in the Metastatic Cascade”
by Enikő Tátrai, Ivan Ranđelović, Sára Eszter Surguta and József Tóvári
Cancers 2024, 16(10), 1872; https://doi.org/10.3390/cancers16101872
Available online: https://www.mdpi.com/2072-6694/16/10/1872
“Circulating Tumour Cells in the Prediction of Bone Metastasis”
by Siu-Wai Choi, Aria Kaiyuan Sun, Jason Pui-Yin Cheung and Jemmi Ching-Ying Ho
Cancers 2024, 16(2), 252; https://doi.org/10.3390/cancers16020252
Available online: https://www.mdpi.com/2072-6694/16/2/252
“The Effect of Non-Overlapping Somatic Mutations in BRAF, NRAS, NF1, or CKIT on the Incidence and Outcome of Brain Metastases during Immune Checkpoint Inhibitor Therapy of Metastatic Melanoma”
by Wolfram Samlowski
Cancers 2024, 16(3), 594;https://doi.org/10.3390/cancers16030594
Available online: https://www.mdpi.com/2072-6694/16/3/594
“Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status”
by Walid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, Alexander Yakobson, Yulia Dudnik, Ashraf Abu Jama, Ahron Yehonatan Cohen, Sondos Shalata, Ahmad Abu Hamed, Tahel Ilan Ber et al.
Cancers 2024, 16(10), 1825https://doi.org/10.3390/cancers16101825
Available online: https://www.mdpi.com/2072-6694/16/10/1825
Special Issues:
|
|
“Breast Cancer Brain Metastasis and Leptomeningeal Disease” |
“Exosomes in Cancer Metastasis” |
|
|
“Educating Recent Updates on Metastatic Non-small Cell Lung Cancer” Guest Editors: Dr. Biswarup Saha and Dr. Hifzur R Siddique Views: 3200+ Submission deadline: 30 June 2025 |
“Advances in Metastatic Prostate Cancer“ Guest Editor: Dr. Orazio Caffo Views: 2200+ Submission deadline: 21 April 2025 |
You are invited to view and submit relevant papers to the journal Cancers at the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office